Aquilla W. v. Commissioner of Social Security

District Court, D. New Jersey·Decided July 24, 2026·No. 2:25-cv-13068·Unknown

Opinion

NOT FOR PUBLICATION

UNITED STATES DISTRICT COURT FOR THE DISTRICT OF NEW JERSEY

AQUILLA W., Civil Action No. 25-13068 (SDW)

Plaintiff, OPINION v.

COMMISSIONER OF SOCIAL July 24, 2026 SECURITY,

Defendant.

WIGENTON, District Judge. Before this Court is Plaintiff Aquilla W.’s (“Plaintiff”)1 appeal of the final administrative decision of the Commissioner of Social Security (“Commissioner”) with respect to Administrative Law Judge Kenneth Ayers’s (“ALJ Ayers”) denial of Plaintiff’s claims for supplemental security income (“SSI”) under the Social Security Act (the “Act”). (D.E. 5-2.) This Court has subject matter jurisdiction pursuant to 42 U.S.C. §§ 405(g) and 1383(c)(3). Venue is proper under 42 U.S.C. § 405(g). This appeal is decided without oral argument pursuant to Federal Rule of Civil Procedure 78. For the reasons set forth below, the Commissioner’s decision is AFFIRMED. I. FACTUAL BACKGROUND

1 Plaintiff is identified only by his first name and last initial in this opinion, pursuant to Standing Order 2021-10, issued on October 1, 2021, available at https://www.njd.uscourts.gov/sites/njd/ files/SO21-10.pdf. Plaintiff was forty-four years old on the date his application was filed, having been born on November 7, 1978, and alleges that he became disabled on February 1, 2018 (the "alleged onset date"). (R. 22, 39.) Plaintiff's disability claim is rooted in a combination of physical impairments (degenerative disc disease of the cervical and lumbar spine and bilateral cubital and carpal tunnel

syndrome) and mental impairments, including anxiety disorder, schizoaffective disorder, bipolar type, post-traumatic stress disorder (“PTSD”), and substance abuse disorder.2 (R. 290, 309–320.) The record reflects that in November 2018, Plaintiff sought treatment reporting a work- related injury sustained approximately one year earlier, with pain in the left side of his body radiating into his left arm and leg. (R. 416.) Examinations through January 2019 showed painful range of motion in his left shoulder, hip, knee, and spine, though with a normal gait and grossly normal strength. (R. 418, 427, 431, 446, 467, 488, 494, 504, 518, 930–31, 1056, 1158, 1165, 1173, 1179, 1206.) Plaintiff was diagnosed with left carpal tunnel syndrome in November 2021 and a January 2022 nerve conduction study confirmed bilateral cubital tunnel syndrome and carpal tunnel syndrome. (R. 904–05, 1158.) He received orthopedic treatment from February 2022

through May 2023 and neurology treatment from April 2022 through November 2023, with examinations in early and mid-2023 showing giveaway weakness in his left forearm and decreased

2 The record also reflects several non-severe or non-medically determinable conditions not at issue in this appeal. Plaintiff had left hip trochanteric bursitis following an October 2021 fall and intermittent right knee effusion first reported in July 2022, both treated conservatively; at his hearing, Plaintiff testified that his hip issue had resolved and his knee was no longer problematic outside of bending or kneeling. (R. 877–79, 882, 66–67, 498, 500, 529, 532.) Plaintiff has also been diagnosed with mild sleep apnea and mixed hypertriglyceridemia, both treated conservatively. (R. 938, 1168.) Additionally, ALJ Ayers found Plaintiff's alleged seizure disorder, traumatic brain injury, neurocognitive disorder, and chest pain not medically determinable: Plaintiff's sole seizure occurred in 2004, well before the application date, with no recurrence as of an August 2024 visit. (R. 396, 992–93, 1127.) The record did not corroborate an alleged 2018 traumatic brain injury in contemporaneous treatment notes. (R. 416, 425, 429.) No cognitive testing predated Plaintiff's workplace injury to support a neurocognitive disorder diagnosis and October 2023 cardiac testing following reported chest pain was normal. (R. 998–1002, 1168.) grip strength and finger movement bilaterally, treated conservatively with nerve-pain medication and antidepressants. (R. 867–922, 932–39, 1123, 1129.) On October 11, 2023, Plaintiff underwent a consultative neurological examination with Rachel Potashnik, M.D. (R. 992–97.) Although the exam revealed bilateral knee swelling, a

fused left fourth digit, and several positive or equivocal provocative findings in his upper extremities, Plaintiff demonstrated the ability to tandem walk and walk on his heels and toes, with normal tone, range of motion, and strength in his upper and lower extremities and functional range of motion in his spine. (Id.) Consultative x-rays showed mild multilevel degenerative disc disease in the cervical spine and mild posterior facet hypertrophy in the lumbar spine, without compression fracture or spondylolisthesis. (Id.) As to his mental health, Plaintiff has received outpatient treatment for bipolar disorder, anxiety, PTSD, and alcohol and cannabis abuse disorder at Rutgers University Behavioral Healthcare since September 2022 and separately received treatment and psychotropic medication management for schizoaffective disorder, bipolar type, and PTSD at Mindful Cognition from April

through October 2023, reporting trouble sleeping, nightmares, racing thoughts, irritability, paranoia, and hallucinations. (R. 387–88, 483, 948–991, 1081–1121.) Mental status examinations spanning April 2023 through September 2024 were inconsistent, at times reflecting an anxious or depressed mood, irritable behavior, pressured speech, flight of ideas, and auditory hallucinations, and at other times reflecting a calm, cooperative presentation with logical thought process, normal memory, normal attention and concentration, and good insight and judgment. (R. 952, 958, 962, 966, 981, 985, 991, 1094–95, 1103, 1106, 1110, 1112.) At the Agency's request, Plaintiff underwent a consultative psychological examination with Robert Rekker, Psy.D., on November 1, 2023. (R. 998–1002.) He reported significant mood swings, sadness, intrusive negative thoughts, paranoia, prior trauma, nightmares, self-isolation, and difficulty with memory and concentration. (Id.) On examination, he had adequate hygiene, good eye contact, and normal speech; he demonstrated intact immediate memory (three of three items) but slightly impaired delayed recall (two of three items), and impaired attention and

concentration, correctly performing simple calculations but unable to complete serial-seven subtraction or spell "world" backward. (Id.) Dr. Rekker diagnosed schizoaffective disorder, bipolar type, PTSD, generalized anxiety disorder, mild neurocognitive disorder due to head trauma, and hallucinogen use disorder in partial remission. (Id.) Plaintiff's self-reported substance use fluctuated over the following months: he reported occasional alcohol and ecstasy use with continued marijuana use in January 2024, approximately three weeks of alcohol sobriety by February 2024, drinking beer two to three times weekly by July 2024, and drinking on multiple days along with two reported ecstasy uses by September 2024. (R. 1086–87, 1097, 1100, 1103–04, 1107, 1110, 1112.) During an August 2024 visit with treating neurologist Khalid Tabbarah, M.D., Plaintiff reported worsening nightmares, difficulty focusing

Free access — add to your briefcase to read the full text and ask questions with AI

Aquilla W. v. Commissioner of Social Security, (D.N.J. 2026).

Aquilla W. v. Commissioner of Social Security (Aquilla W. v. Commissioner of Social Security) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related